These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

692 related articles for article (PubMed ID: 7626351)

  • 1. Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment.
    Lip GY; Lowe GD; Rumley A; Dunn FG
    Br Heart J; 1995 Jun; 73(6):527-33. PubMed ID: 7626351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation.
    Li-Saw-Hee FL; Blann AD; Lip GY
    Stroke; 2000 Apr; 31(4):828-33. PubMed ID: 10753983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of warfarin therapy on plasma fibrinogen, von Willebrand factor, and fibrin D-dimer in left ventricular dysfunction secondary to coronary artery disease with and without aneurysms.
    Lip GY; Lowe GD; Metcalfe MJ; Rumley A; Dunn FG
    Am J Cardiol; 1995 Sep; 76(7):453-8. PubMed ID: 7653443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin.
    Lip GY; Lip PL; Zarifis J; Watson RD; Bareford D; Lowe GD; Beevers DG
    Circulation; 1996 Aug; 94(3):425-31. PubMed ID: 8759084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma fibrinogen and fibrin D-dimer in patients with atrial fibrillation: effects of cardioversion to sinus rhythm.
    Lip GY; Rumley A; Dunn FG; Lowe GD
    Int J Cardiol; 1995 Oct; 51(3):245-51. PubMed ID: 8586473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of coagulation occurs after electrical cardioversion in patients with chronic atrial fibrillation despite optimal anticoagulation with warfarin.
    Jacob K; Talwar S; Copplestone A; Gilbert TJ; Haywood GA
    Int J Cardiol; 2004 May; 95(1):83-8. PubMed ID: 15159043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy.
    Kamath S; Blann AD; Chin BS; Lanza F; Aleil B; Cazenave JP; Lip GY
    Eur Heart J; 2002 Nov; 23(22):1788-95. PubMed ID: 12419299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation.
    Kamath S; Blann AD; Chin BS; Lip GY
    J Am Coll Cardiol; 2002 Aug; 40(3):484-90. PubMed ID: 12142115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: evidence for intermediate elevated levels of intravascular thrombogenesis.
    Lip GY; Lowe GD; Rumley A; Dunn FG
    Am Heart J; 1996 Apr; 131(4):724-30. PubMed ID: 8721646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients.
    Roldán V; Marín F; Muiña B; Torregrosa JM; Hernández-Romero D; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2011 Jun; 57(25):2496-504. PubMed ID: 21497043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation.
    Marín F; Roldán V; Climent VE; Ibáñez A; García A; Marco P; Sogorb F; Lip GY
    Heart; 2004 Oct; 90(10):1162-6. PubMed ID: 15367514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy.
    Lip GY; Blann AD; Jones AF; Lip PL; Beevers DG
    Am J Cardiol; 1997 Dec; 80(12):1566-71. PubMed ID: 9416937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is diastolic dysfunction associated with thrombogenesis? A study of circulating markers of a prothrombotic state in patients with coronary artery disease.
    Lip GY; Lowe GD; Metcalfe MJ; Rumley A; Dunn FG
    Int J Cardiol; 1995 Jun; 50(1):31-42. PubMed ID: 7558462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombogenesis in mitral regurgitation and aortic stenosis.
    Lip GY; Rumley A; Dunn FG; Lowe GD
    Angiology; 1996 Dec; 47(12):1117-25. PubMed ID: 8956663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indexes of hypercoagulability measured in peripheral blood reflect levels in intracardiac blood in patients with atrial fibrillation secondary to mitral stenosis.
    Li-Saw-Hee FL; Blann AD; Goldsmith I; Lip GY
    Am J Cardiol; 1999 Apr; 83(8):1206-9. PubMed ID: 10215285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonvalvular atrial fibrillation: evidence for a prothrombotic state.
    Kahn SR; Solymoss S; Flegel KM
    CMAJ; 1997 Sep; 157(6):673-81. PubMed ID: 9307553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrin D-dimer, tissue-type plasminogen activator, von Willebrand factor, and risk of incident stroke in older men.
    Wannamethee SG; Whincup PH; Lennon L; Rumley A; Lowe GD
    Stroke; 2012 May; 43(5):1206-11. PubMed ID: 22382157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D-dimer and factor VIIa in atrial fibrillation - prognostic values for cardiovascular events and effects of anticoagulation therapy. A RE-LY substudy.
    Siegbahn A; Oldgren J; Andersson U; Ezekowitz MD; Reilly PA; Connolly SJ; Yusuf S; Wallentin L; Eikelboom JW
    Thromb Haemost; 2016 May; 115(5):921-30. PubMed ID: 26818781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function.
    Li-Saw-Hee FL; Blann AD; Gurney D; Lip GY
    Eur Heart J; 2001 Sep; 22(18):1741-7. PubMed ID: 11511124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of plasma fibrinogen, D-dimer, and the von Willebrand factor as markers of cardiovascular morbidity in patients on chronic hemodialysis.
    Kirmizis D; Tsiandoulas A; Pangalou M; Koutoupa E; Rozi P; Protopappa M; Barboutis K
    Med Sci Monit; 2006 Feb; 12(2):CR55-62. PubMed ID: 16449948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.